GeneDx Holdings Corp. (WGS) — Capital Reinvestment Ratio
GeneDx Holdings Corp. (WGS) has a Capital Reinvestment Ratio of 0.39x as of September 2025, meaning it reinvests 0% of its operating cash flow ($15.77 Million) in capital expenditures ($6.17 Million). Check GeneDx Holdings Corp. (WGS) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
GeneDx Holdings Corp. Capital Reinvestment Ratio (2025–2025)
This chart tracks GeneDx Holdings Corp.'s Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see GeneDx Holdings Corp. (WGS) cash conversion ratio.
Annual Capital Reinvestment Ratio for GeneDx Holdings Corp. (2025–2025)
Year-by-year Capital Reinvestment Ratio for GeneDx Holdings Corp. from 2025 to 2025. See GeneDx Holdings Corp. (WGS) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.57x | $33.28 Million | $19.02 Million | — |